Bassey Eyo, a mother of three, living in Cross River State was delighted that she and her child could receive the COVID-19 vaccine and the novel Oral Polio Vaccine (nOPV2) respectively at a health center in Big Qua.
She had travelled 5 miles to get to Big Qua town with the hope of accessing both vaccines.
“I am happy that I had the opportunity to receive the COVID 19 vaccination and polio vaccine for my eligible child within the same health facility. We do not have access to the services in the village where my family lives. It was my husband who directed me to Big Qua Town (his hometown). I received the COVID-19 vaccine, and my child got his polio vaccination, and we are both doing well,” she said.
For Joan Ewah, an N-Power staff, the availability of both vaccines at the health center where he took his COVID-19 jab encouraged him to take his children to receive the polio vaccine.
“I am excited that both vaccines are accessible as they would encourage many people who bring their children for the Polio vaccine to receive the COVID-19 vaccine. As a parent, I would not like to have a child that is deformed,” he said.
To encourage the uptake of COVID-19 vaccination, the Cross River State Government, with support from the World Health Organization (WHO), leveraged the polio vaccination campaign by integrating the Covid-19 vaccination.
On 25 August 2020, Nigeria and the WHO Africa region was certified polio-free after achieving the wild polio virus-free status. However, Nigeria is still combating the Circulating Vaccine Derived Polio Virus Type 2 (cVDPV2), and as a result, necessitated sustain nOPV2 vaccination across the country. From January to September 2021, 22 states reported 327 confirmed cases of cVDPV2. However, Cross River State has not reported any case.
Nevertheless, for preventive measures, the Cross River State Government, supported by partners, implemented a four-days outbreak response (OBR) as a proactive measure to protect all eligible children (0-59 months).
Also, Nigeria is currently combating the COVID-19 pandemic, with 209 546 cases reported and 2838 death as of 19 October 2021. Of which, Cross River state has reported 614 cases.
At the vaccination campaign flag-of, the Commissioner for Health, Dr Betta Edu, said the concept was to provide service to the eligible children and their parents in an integrated manner to ensure that the parent gets access to the COVID-19 vaccine.
The 4-day exercise (02 - 05 October 2021) targeted to reach 887 162 children with the nOPV2 vaccine in the 18 Local Government Areas (LGAs). At the end of the campaign, 926732 children had received the nOPV2 vaccine, and 124,524 and 59,843 eligible persons received the first and the second dose of COVID 19 vaccines.
Speaking on the importance of the integration of the vaccination campaign, Dr Edu said the approach would avail parents who bring their children for nOPV2 vaccination to obtain the COVID-19 shot.
Both polio and COVID 19 vaccines are available across the health centers. We have advised that the service should use an integrated approach to reduce missed vaccination opportunities.
In her remark, the Director-General, Cross River State Primary Health Care Development Agency Dr. Janet
Ekpenyong, said prevention of infectious diseases is a fight everybody must join.
To ensure that we do not record any case of cVDPV2 in Cross River state, all hands must be on deck. We are currently responding to COVID- 19 outbreak, and we would not like to combat any other vaccine-preventable diseases. We have introduced the high impact interventions to bridge existing vaccination gaps, and we encourage eligible persons to present themselves for vaccination, she said.
Representing the WHO Acting State Coordinator, Dr Biniam Getachew reiterated the importance of the OBR campaign and implementation of routine immunization to interrupt vaccine-preventable diseases in Nigeria.
Appreciating the vaccination teams for their coordination, he said, “WHO will continue to provide the necessary support to scale up provision of integrated service delivery towards the achievement of Universal Health Coverage.”
Distributed by APO Group on behalf of World Health Organization (WHO) - Nigeria.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
